Weight-Loss drug tested on people with kidney problems
NCT ID NCT07076030
Summary
This study looked at how a new weight management drug called petrelintide is processed by the body in people with different levels of kidney function. Researchers gave a single dose to 39 adults, some with normal kidneys and some with mild, moderate, or severe kidney impairment. The main goal was to see if the drug behaves differently in people with kidney problems, which is important for future safe use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité Research Organisation GmbH
Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.